31起交易超93亿美元!石药与阿斯利康达成超53亿美元合作、代谢领域诺和诺德与礼来新动作 | 一周交易

创鉴汇
Jun 19, 2025

据创鉴汇不完全统计,6月9日至6月15日全球生物制药领域共披露31起交易事件,潜在交易总额超93.6亿美元,超亿美元的大额交易达5起。交易类型以16起合作研发和10起药物授权为主,并购与技术授权各占少数。药物类型涵盖广泛,包括小分子药物、抗体类药物、核素偶联药物、treg细胞疗法等。大额交易聚焦肿瘤、慢病与神经领域:石药集团与阿斯利康达成潜在交易总额53.3亿美元的战略合作,将利用AI平台共同发现...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10